Skip to menu Skip to content Skip to footer

2008

Journal Article

How to treat: Proteinuria

Johnson, David W. and Mathew, Timothy (2008). How to treat: Proteinuria. Australian Doctor, 1 February, 17-19, 22-24.

How to treat: Proteinuria

2008

Journal Article

Automated and continuous ambulatory peritoneal dialysis have similar outcomes

Badve, S., Hawley, C. M., McDonald, S., Mudge, D., Rosman, J., Brown, F. and Johnson, D. W. (2008). Automated and continuous ambulatory peritoneal dialysis have similar outcomes. Kidney International, 73 (4), 480-488. doi: 10.1038/sj.ki.5002705

Automated and continuous ambulatory peritoneal dialysis have similar outcomes

2008

Conference Publication

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

Kaisar, M., Armstrong, K., Prins, J., Marwick, T., Johnson, D., Hawley, C. and Isbel, N. (2008). The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology , Newcastle, Australia, 6–10 September 2008. Hoboken, NJ United States: Wiley-Blackwell.

The impact of aggressive cardiovascular risk modification on carotid intima media thickness and brachial artery reactivity in renal transplant recipients

2008

Journal Article

Change in live donor characteristics over the last 25 years: A single centre experience

Kaisar, Mohd O., Nicol, David L., Hawley, Carmel M., Mudge, David W., Johnson, David W., Preston, John M., Wall, Daryl R., Griffin, Anthony D., Campbell, Scott B. and Isbel, Nicole M. (2008). Change in live donor characteristics over the last 25 years: A single centre experience. Nephrology, 13 (7), 646-650. doi: 10.1111/j.1440-1797.2008.01039.x

Change in live donor characteristics over the last 25 years: A single centre experience

2008

Book Chapter

How to treat proteinuria

Johnson, David W. and Mathew, Timothy (2008). How to treat proteinuria. How to treat: Australia's leading series on primary care treatment. Yearbook, 2008.. (pp. xx-xx) edited by Gavathas. Chatswood, N.S.W., Australia: Reed Business Information.

How to treat proteinuria

2008

Conference Publication

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

Gobe, G. C., Johnson, D. W., Li, J., Pat, B. K., Percy, C. J. and Rajandram, R. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell.

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Journal Article

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

Kaisar, Omar M., Johnson, David W., Prins, Judith B. and Isbel, Nicole (2008). The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin. Current Cardiology Reviews, 4 (4), 287-292. doi: 10.2174/157340308786349516

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

2008

Conference Publication

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

Percy, Christine, Brown, L., Johnson, D. W. and Gobe, G. (2008). Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing. Australian and New Zealand Society of Nephrology (ANZSN) Annual Conference, Newcastle, Australia, 6-10 September 2008.

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

2008

Conference Publication

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING.

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

Gobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology.

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

2008

Conference Publication

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell .

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

2008

Journal Article

Pure red cell aplasia induced by erythropoiesis-stimulating agents

Pollock, C., Johnson, D. W., Horl, W., Rossert, J., Casadevall, N., Schellekens, H., Delage, R., De Francisco, A., Macdougall, I., Thorpe, R. and Toffelmire, E. (2008). Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clinical Journal of the American Society of Nephrology, 3 (1), 193-199. doi: 10.2215/CJN.02440607

Pure red cell aplasia induced by erythropoiesis-stimulating agents

2008

Journal Article

The impact of automated eGFR reporting and education on nephrology service referrals

Noble, E, Johnson, DW, Gray, N, Hollett, P, Hawley, CM, Campbell, SB, Mudge, DW and Isbel, NM (2008). The impact of automated eGFR reporting and education on nephrology service referrals. Nephrology, Dialysis, Transplantation, 23 (12), 3845-3850. doi: 10.1093/ndt/gfn385

The impact of automated eGFR reporting and education on nephrology service referrals

2008

Book Chapter

Use of honey to prevent infections associated with medical devices

Miles, R. and Johnson, D. W. (2008). Use of honey to prevent infections associated with medical devices. Honey: A modern wound management product. (pp. 91-105) edited by Rose Cooper, Peter Molan and Richard White. Aberdeen, United Kingdom: Wounds UK Publishing.

Use of honey to prevent infections associated with medical devices

2008

Conference Publication

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

Brooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation